Browse Title Index


 
Issue Title
 
Vol 15 (2008): Supplement - Integrative Oncology: A Canadian and International Perspective How to put wellness on the prescription pad Abstract   PDF
Paul Fortin
 
Vol 20, No 4 (2013) HPV is here to stay Abstract   PDF   HTML
M. Corsten
 
Vol 25, No 1 (2018) HPV self-sampling article collection: e-manuscript summaries Abstract   PDF   HTML
Various Authors
 
Vol 25, No 1 (2018) HPV self-sampling: A promising approach to reduce cervical cancer screening disparities in Canada Abstract   PDF   HTML
M. Vahabi, A. Lofters
 
Vol 23, No 4 (2016) HPV vaccines? Still needed Abstract   PDF   HTML
L.Z.G. Touyz
 
Vol 21, No 5 (2014) Hsp90 inhibitors in oncology: ready for prime time? Abstract   PDF   HTML
S. Parimi, R.Y. Tsang
 
Vol 22, No 5 (2015) Human albumin eye drops as a therapeutic option for the management of keratoconjunctivitis sicca secondary to chronic graft-versus-host disease after stem-cell allografting Abstract   PDF   HTML
J.T. Seki, N. Sakurai, S. Moldenhauer, J. Dam, E.G. Atenafu, P.M. Yip, T. Mazzulli, T. Henderson, J. Pendergrast, C. Cserti, J.P. Velazquez, R. Simpson, G. Felluga, H.A. Messner, J.H. Lipton
 
Vol 16, No 4 (2009) Human Papilloma Virus inoculation: Why only girls? Abstract   PDF
Louis Zalman Glick Touyz
 
Vol 26, No 2 (2019) Human papillomavirus–associated oropharyngeal cancer: review of current evidence and management Abstract   PDF   HTML
E. L. You, M. Henry, A. G. Zeitouni
 
Vol 19, No 3 (2012) Humps and bumps: feel them ... like it or lump it Details   PDF   HTML
L. Z.G. Touyz
 
Vol 21, No 5 (2014) Hyperammonemic encephalopathy in an adenocarcinoma patient managed with carglumic acid Abstract   PDF   HTML
J. Lazier, S.M. Lupichuk, I. Sosova, A.A. Khan
 
Vol 18, No 5 (2011) Hyperbaric oxygen for radiation injury: is it indicated? Details   PDF   HTML
J. J. Feldmeier
 
Vol 18, No 5 (2011) Hyperbaric oxygen therapy for late radiation tissue injury in gynecologic malignancies Abstract   PDF   HTML
P. Craighead, M. A. Shea-Budgell, J. Nation, R. Esmail, A. W. Evans, M. Parliament, T. K. Oliver, N. A. Hagen
 
Vol 25, No 6 (2018) Hypertension as a predictor of advanced colorectal cancer outcome and Cetuximab treatment response Abstract   PDF   HTML
S. Sud, C. O'Callaghan, C. Jonker, C. Karapetis, T. Price, N. Tebbutt, J. Shapiro, G. Van Hazel, N. Pavlakis, P. Gibbs, M. Jeffrey, L. Siu, S. Gill, R. Wong, D. Jonker, D. Tu, R. Goodwin
 
Vol 19, No 4 (2012) Hypertension management in patients with renal cell cancer treated with anti-angiogenic agents Abstract   PDF   HTML
P. Larochelle, C. Kollmannsberger, R. D. Feldman, E. L. Schiffrin, L. Poirier, F. Patenaude, D. Ruether, M. Myers, G. Bjarnason
 
Vol 17, No 5 (2010) Hypofractionated radiotherapy and adjuvant chemotherapy do not increase radiation-induced dermatitis in breast cancer patients Abstract   PDF
T. Hijal, A.A. Al Hamad, T. Niazi, K. Sultanem, B. Bahoric, T. Vuong, T. Muanza
 
Vol 23, No 4 (2016) Hypopharyngeal cancer: looking back, moving forward Abstract   PDF   HTML
D. Day, A.R. Hansen, L.L. Siu
 
Vol 23, No 2 (2016) Identification of performance indicators across a network of clinical cancer programs Abstract   PDF   HTML
S.R. Khare, G. Batist, G. Bartlett
 
Vol 24, No 6 (2017) Identifying barriers to accrual in radiation oncology randomized trials Abstract   PDF   HTML
J.M. Laba, S. Senan, D. Schellenberg, S. Harrow, L. Mulroy, S. Senthi, A. Swaminath, N. Kopek, J.R. Pantarotto, L. Pan, A. Pearce, A. Warner, A.V. Louie, D.A. Palma
 
Vol 14, No 4 (2007) Ifosfamide-based combination chemotherapy in advanced soft tissue sarcoma: a systematic review and clinical practice guideline. Details   PDF
Denise Stys-Norman, Lisa Vandermeer, Shailendra Verma
 
Vol 22, No 5 (2015) Imatinib for highly chemoresistant Kaposi sarcoma in a patient with long-term HIV control: a case report and literature review Abstract   PDF   HTML
W. Cao, K. Vyboh, B. Routy, M. Chababi-Atallah, B. Lemire, J.P. Routy
 
Vol 18, No 1 (2011) Immune therapy for breast cancer in 2010—hype or hope? Abstract   PDF   HTML
A. Florescu, E. Amir, N. Bouganim, M. Clemons
 
Vol 20, No 2 (2013) Immune toxicities and long remission duration following ipilimumab therapy for metastatic melanoma: two illustrative cases Abstract   PDF   HTML
H. Assi, K.S. Wilson
 
Vol 25, No 5 (2018) Immune-related adverse events of immune checkpoint inhibitors: a brief review Abstract   PDF   HTML
G. Myers
 
Vol 23, No 2 (2016) Immunotherapy with imiquimod and interferon alfa for metastasized Merkel cell carcinoma Abstract   PDF   HTML
R.U. Wahl, T. Braunschweig, A. Ghassemi, A. Rübben
 
Vol 15 (2008): Supplement - Integrative Oncology: A Canadian and International Perspective Impact and Outcomes of an Iyengar Yoga Program in a Cancer Centre Abstract   PDF
Meghan D Duncan
 
Vol 26, No 2 (2019) Impact of a novel prioritization framework on clinician-led oncology drug submissions Abstract   PDF   HTML   Supplemental Material
J. Keech, J. Beca, A. Eisen, E. Kennedy, J. Kim, C. T. Kouroukis, G. Darling, S. E. Ferguson, A. Finelli, T. M. Petrella, J. R. Perry, K. Chan, S. Gavura
 
Vol 20, No 2 (2013) Impact of a single-day multidisciplinary clinic on the management of patients with liver tumors Abstract   PDF   HTML
J. Zhang, M.N. Mavros, D. Cosgrove, K. Hirose, J.M. Herman, S. Smallwood-Massey, I. Kamel, A. Gurakar, R. Anders, A. Cameron, J.F.H. Geschwind, T.M. Pawlik
 
Vol 22, No 6 (2015) Impact of country-specific EQ-5D-3L tariffs on the economic value of systemic therapies used in the treatment of metastatic pancreatic cancer Abstract   PDF   HTML
K. Lien, V.C. Tam, Y.J. Ko, N. Mittmann, M.C. Cheung, K.K.W. Chan
 
Vol 13, No 3 (2006) Impact of geometric uncertainties on the dose distribution during intensity-modulated radiotherapy (IMRT) of head and neck cancer: the need for planning target volume (PTV) and planning organ at risk volume (PRV). Details   PDF
Olivier Ballivy, William Parker, Te Vuong, George Shenouda, Horacio Patrocinio
 
Vol 21, No 1 (2014) Impact of granulocyte colony–stimulating factors in metastatic colorectal cancer patients Abstract   PDF   HTML
A. Amadio, R. Burkes, T. Bailie, M. McLean, B. Coleman
 
Vol 25, No 6 (2018) Impact of high-fidelity e-learning on knowledge acquisition and satisfaction in radiation oncology trainees Abstract   PDF   HTML
C. Gillan, J. Papadakos, J. Brual, N. Harnett, A. Hogan, E. Milne, M. E. Giuliani
 
Vol 23, No 1 (2016) Impact of oxaliplatin-induced neuropathy in patients with colorectal cancer: a prospective evaluation at a single institution Abstract   PDF   HTML
R. Dault, M.P. Rousseau, A. Beaudoin, M.A. Frenette, F. Lemay, M.F. Beauchesne
 
Vol 16, No 6 (2009) Impact of radiation avoidance on survival and neurocognitive outcome in infant medulloblastoma Abstract   PDF
L. Lafay-Cousin, E. Bouffet, C. Hawkins, A. Amid, A. Huang, D. Mabbott
 
Vol 21, No 5 (2014) Impact of screening mammography on mortality from breast cancer before age 60 in women 40 to 49 years of age Abstract   PDF   HTML
S. Narod, P. Sun, C. Wall, C. Baines, A.B. Miller
 
Vol 26, No 2 (2019) Impact of spleen-preserving total gastrectomy on postoperative infectious complications and 5-year overall survival: systematic review and meta-analysis of contemporary randomized clinical trials Abstract   PDF   HTML
A. Aiolfi, E. Asti, S. Siboni, D. Bernardi, E. Rausa, G. Bonitta, L. Bonavina
 
Vol 20, No 4 (2013) Impact of the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology clinical practice guidelines for EGFR and ALK testing in lung cancer in Canada Abstract   PDF   HTML
D.N. Ionescu
 
Vol 24, No 5 (2017) Impact of the pan-Canadian Oncology Drug Review on provincial concordance with respect to cancer drug funding decisions and time to funding Abstract   PDF   HTML
A. Srikanthan, H. Mai, N. Penner, E. Amir, A. Laupacis, M. Sabharwal, K.K.W. Chan
 
Vol 25, No 1 (2018) Impact of the Spinal Instability Neoplastic Score on Surgical Referral Patterns and Outcomes Abstract   PDF   HTML
M. Dosani, S. Lucas, J. Wong, L. Weir, S. Lomas, C. Cumayas, C. Fisher, S. Tyldesley
 
Vol 18, No 3 (2011) Impact of tumour volume on the potential efficacy of therapeutic vaccines Abstract   PDF   HTML
J. L. Gulley, R. A. Madan, J. Schlom
 
Vol 25, No 1 (2018) Implementation considerations using HPV self-collection to reach women under-screened for cervical cancer in high-income settings Abstract   PDF   HTML
H.N. Pedersen, L.W. Smith, C. Racey, D. Cook, M. Krajden, D. van Niekerk, G.S. Ogilvie
 
Vol 21, No 5 (2014) Implementing a regional oncology information system: approach and lessons learned Abstract   PDF   HTML
W.K. Evans, F.D. Ashbury, G.L. Hogue, A. Smith, J. Pun
 
Vol 23, No 3 (2016) Implementing low-dose computed tomography screening for lung cancer in Canada: implications of alternative at-risk populations, screening frequency, and duration Abstract   PDF   HTML
W.K. Evans, W.M. Flanagan, A.B. Miller, J.R. Goffin, S. Memon, N. Fitzgerald, M.C. Wolfson
 
Vol 23 (2016): Original Cancer Costing Research Using Canadian Data Importance of cost estimates and cost studies Abstract   PDF   HTML
N. Mittmann, C. de Oliveira
 
Vol 22, No 6 (2015) Improving access to cancer guidelines: feedback from health care professionals Abstract   PDF   HTML
I.S. Sahota, X. Kostaras, N.A. Hagen
 
Vol 18, No 2 (2011) Improving cancer control in Canada one case at a time: the “Knowledge Translation in Cancer” casebook Abstract   PDF   APPENDIX A   APPENDIX B   HTML
M. Brouwers, J. Makarski, K. Garcia, S. Bouseh, T. Hafid
 
Vol 19, No 2 (2012) Improving cancer control in Canada through knowledge translation: from in-the-field projects to policy initiatives in a new standing section in Current Oncology Abstract   PDF   HTML
M.A. O'Brien, E. Grunfeld
 
Vol 24, No 2 (2017) Improving molecular testing and personalized medicine in non-small-cell lung cancer in Ontario Abstract   PDF   HTML
C. Lim, H.S. Sekhon, J.C. Cutz, D.M. Hwang, S. Kamel-Reid, R.F. Carter, G. da Cunha Santos, T. Waddell, M. Binnie, M. Patel, N. Paul, T. Chung, A. Brade, R. El-Maraghi, C. Sit, M.S. Tsao, N.B. Leighl
 
Vol 23, No 3 (2016) Improving patient flow and timeliness in the diagnosis and management of breast abnormalities: the impact of a rapid diagnostic unit Abstract   PDF   HTML
J.M. Racz, C.M.B. Holloway, W. Huang, N.J. Look Hong
 
Vol 25, No 1 (2018) Improving pneumococcal vaccine uptake in veterans with chronic lymphocytic leukemia through a virtual clinic Abstract   PDF   HTML
E.C. Church, R. Banks, B. Wilson, L. Arfons, F. Perez, R. Jump
 
Vol 19, No 6 (2012) Improving referral of patients for consideration of adjuvant chemotherapy after surgical resection of lung cancer Abstract   PDF   HTML
J.A. Zuccato, P.M. Ellis
 
Vol 19, No 6 (2012) Improving the quality of abstract reporting for economic analyses in oncology Abstract   PDF   HTML
M.Y. Ho, K.K. Chan, S. Peacock, W.Y. Cheung
 
Vol 22, No 1 (2015) In 2124, half of all men can count on developing prostate cancer Abstract   PDF   HTML
P.A. Pollock, A. Ludgate, R.J. Wassersug
 
Vol 22, No 4 (2015) In serum, higher parathyroid hormone but not lower vitamin D is associated with oral squamous cell carcinoma Abstract   PDF   HTML
H. Zhang, H. Lu, C. Shrestha, Y. Feng, Y. Li, J. Peng, Y. Li, Z. Xie
 
Vol 17, No 4 (2010) In support of Canada’s health care system: an oncologist’s perspective Abstract   PDF
A. Ali Zaidi
 
Vol 16, No 6 (2009) In this issue of Current Oncology Abstract   PDF
Mike McLean
 
Vol 17, No 1 (2010) In this issue of Current Oncology Abstract   PDF
Mike McLean
 
Vol 17, No 2 (2010) In this issue of Current Oncology Abstract   PDF
Mike McLean
 
Vol 17, No 3 (2010) In this issue of Current Oncology Abstract   PDF
Mike McLean
 
Vol 17, No 4 (2010) In this issue of Current Oncology Abstract   PDF
Mike McLean
 
Vol 17, No 5 (2010) In this issue of Current Oncology Abstract   PDF
M. McLean
 
Vol 17, No 6 (2010) In this issue of Current Oncology Details   PDF
M. McLean
 
Vol 19, No 3 (2012) In this issue of Current Oncology Details   PDF   HTML
M. Chasen
 
Vol 23 (2016): Use of Cannabinoids in Cancer Care In vitro and in vivo efficacy of non-psychoactive cannabidiol in neuroblastoma Abstract   PDF   HTML
T. Fisher, H. Golan, G. Schiby, S. PriChen, R. Smoum, I. Moshe, N. Peshes-Yaloz, A. Castiel, D. Waldman, R. Gallily, R. Mechoulam, A. Toren
 
Vol 23, No 1 (2016) In vitro and in vivo studies on the inhibitory effects of myocardial cell culture medium on growth of a human lung adenocarcinoma cell line, A549 Abstract   PDF   HTML
Y. Zheng, J. Zhou, S.Z. Fu, J. Fan, J.B. Wu
 
Vol 19, No 3 (2012) Incidence of febrile neutropenia during adjuvant chemotherapy for breast cancer: a prospective study Abstract   PDF   HTML
D. Rayson, S. Lutes, M. Sellon, B. Colwell, M. Dorreen, A. Drucker, A. Jeyakumar, S. Snow, T. Younis
 
Vol 26, No 3 (2019) Incidence of radionecrosis in single-fraction radiosurgery compared with fractionated radiotherapy in the treatment of brain metastasis Abstract   PDF   HTML
E. K. Donovan, S. Parpia, J. N. Greenspoon
 
Vol 25, No 6 (2018) Incidence of spinal disease and role of spinal radiotherapy in multiple myeloma Abstract   PDF   HTML
A. M. Sharma, M. Sackett, D. Bueddefeld, P. Lambert, A. Dubey, V. Wadhwa, R. Kotb, N. Ahmed
 
Vol 17, No 4 (2010) Incidence of taxane-induced pain and distress in patients receiving chemotherapy for early-stage breast cancer: a retrospective, outcomes-based survey Abstract   PDF
S. Saibil, B. Fitzgerald, O.C. Freedman, E. Amir, J. Napolskikh, N. Salvo, G. Dranitsaris, M. Clemons
 
Vol 19, No 1 (2012) Increased alpha-fetoprotein receptor in the serum of patients with early-stage breast cancer Abstract   PDF   HTML
R. Moro, J. Gulyaeva–Tcherkassova, P. Stieber
 
Vol 22, No 4 (2015) Increased treatment related toxicity subsequent to an anti-PD1 agent Abstract   PDF   HTML
L. Khoja, M.O. Butler, M.A. Chappell, D. Hogg, A.M. Joshua
 
Vol 20, No 1 (2013) Indicator measures er/pr and her2 testing among women with invasive breast cancer Abstract   PDF   HTML
C. Sandoval, R. Rahal, T. Forte, J. Klein–Geltink, D. He, H. Bryant
 
Vol 13, No 4 (2006) Influenza Pandemic Planning for Cancer Patients Details   PDF
Peter Malcolm Battershill
 
Vol 21, No 4 (2014) Information needs and sources of information for patients during cancer follow-up Abstract   PDF   HTML
M.A. Shea-Budgell, X. Kostaras, K.P. Myhill, N.A. Hagen
 
Vol 16, No 3 (2009) Informational stories: a complementary strategy for patients and caregivers with brain metastases Abstract   PDF
Rebecca Wong, A. D Chung, D. Ng, L. Wang, C. Garraway, A. Bezjak, J. Nyhof-Young
 
Vol 20, No 2 (2013) Informing Canada’s cancer drug funding decisions with scientific evidence and patient perspectives: the pan-Canadian Oncology Drug Review Abstract   PDF   HTML
J.S. Hoch, M. Sabharwal
 
Vol 26, No 3 (2019) Initial management of small-cell lung cancer (limited- and extensive-stage) and the role of thoracic radiotherapy and first-line chemotherapy: a systematic review Abstract   PDF   HTML
A. Sun, L. D. Durocher-Allen, P. M. Ellis, Y. C. Ung, J. R. Goffin, K. Ramchandar, G. Darling
 
Vol 17, No 6 (2010) Initial McGill experience with fluorodeoxyglucose PET/CT staging of soft-tissue sarcoma Abstract   PDF
D. Roberge, M. Hickeson, M. Charest, R.E. Turcotte
 
2008: Presentations from the Integrating Wellness into Cancer Care Conference InspireHealth: Integrative Cancer Care Experience Abstract   PPT Presentation
Hal Gunn
 
Vol 23 (2016): Use of Cannabinoids in Cancer Care Integrating cannabis into clinical cancer care Abstract   PDF   HTML
D.I. Abrams
 
Vol 26, No 1 (2019) Integrating primary care providers through the seasons of survivorship Abstract   PDF   HTML
G. Chaput, J. Sussman
 
Vol 14, No 6 (2007) Integrating Regional and Community Lung Cancer Services to Improve Patient Care Abstract   PDF
Max Dahele, Yee Ung, Jacinta Meharchand, Harry Shulman, Robert Zeldin, Abdollah Behzadi, Carmine Simone, Susanna Cheng, Corey Weigensberg, Khalil Sivjee
 
Vol 15 (2008): Supplement - Integrative Oncology: A Canadian and International Perspective Integrating Science and Human Values for Cancer Patient Care Abstract   PDF
Simon Sutcliffe
 
2008: Presentations from the Integrating Wellness into Cancer Care Conference Integrating Science and Human Values for Cancer Patient Care Abstract   PPT Presentation
Simon B. Sutcliffe
 
2008: Presentations from the Integrating Wellness into Cancer Care Conference Integrating Spirituality in Healthcare Abstract   PPT Presentation
Gary Payne
 
2008: Presentations from the Integrating Wellness into Cancer Care Conference Integrating Wellness into Cancer Care Abstract   PPT Presentation
Presenter Fortin
 
2008: Presentations from the Integrating Wellness into Cancer Care Conference Integrating Wellness Into Cancer Care: Things I have learned Abstract   PPT Presentation
Ida Ackerman
 
Vol 23, No 3 (2016) Integration of a nurse navigator into the triage process for patients with non-small-cell lung cancer: creating systematic improvements in patient care Abstract   PDF   HTML
K. Zibrik, J. Laskin, C. Ho
 
2008: Presentations from the Integrating Wellness into Cancer Care Conference Integrative Cancer Care in an Academic Cancer Centre in the U.S. Abstract   PPT Presentation
Gary Deng
 
Vol 15 (2008): Supplement - Integrative Oncology: A Canadian and International Perspective Integrative Cancer Care in an American Academic Cancer Centre: The Memorial Sloan Kettering Experience Abstract   PDF   Photos (PDF)
Gary Deng
 
2008: Presentations from the Integrating Wellness into Cancer Care Conference Integrative Oncology to Improve Outcomes of Care Abstract   PPT Presentation
Stephen Sagar
 
Vol 15 (2008): Supplement - Integrative Oncology: A Canadian and International Perspective Integrative Oncology: A Canadian and International Perspective Abstract   PDF
Stephen Sagar, Anne Leis
 
2008: Presentations from the Integrating Wellness into Cancer Care Conference Integrative Oncology: A Community Hospital Perspective Abstract   PPT Presentation
Leonard Wright
 
Vol 15 (2008): Supplement - Integrative Oncology: A Canadian and International Perspective Integrative practices of Canadian oncology health professionals Abstract   PDF
Alison SA Brazier
 
Vol 17, No 6 (2010) Intensive induction chemotherapy without methotrexate in adult patients with localized osteosarcoma: results of the Institut Gustave-Roussy phase II trial Abstract   PDF
H. Assi, G. Missenard, P. Terrier, C. Le Pechoux, S. Bonvalot, D. Vanel, J.B. Meric, T. Tursz, A. LeCesne
 
Vol 15 (2008): Supplement - Integrative Oncology: A Canadian and International Perspective Interactions of Complementary Therapies with Biomedical Cancer Treatments Abstract   PDF
Dugald Seely
 
Vol 17, No 1 (2010) Inter-institutional pathology consultations for breast cancer: impact on clinical oncology therapy recommendations Abstract   PDF
J.A. Price, E. Grunfeld, P.J. Barnes, D.E. Rheaume, D. Rayson
 
Vol 17 (2010): Managing Prostate Cancer in 2010 and Beyond: A Canadian Perspective Intermittent versus continuous androgen suppression therapy: do we have consensus yet? Abstract   PDF
N. C. Buchan, S. L. Goldenberg
 
Vol 19, No 3 (2012) International variability in the reimbursement of cancer drugs by publically funded drug programs Abstract   PDF   HTML
P. K. Cheema, S. Gavura, M. Migus, B. Godman, L. Yeung, M. E Trudeau
 
Vol 18, No 6 (2011) Inter-rater reliability between musculoskeletal radiologists and orthopedic surgeons on computed tomography imaging features of spinal metastases Abstract   PDF   HTML
L. Khan, G. Mitera, L. Probyn, M. Ford, M. Christakis, J. Finkelstein, A. Donovan, L. Zhang, L. Zeng, J. Rubenstein, A. Yee, L. Holden, E. Chow
 
701 - 800 of 1627 Items << < 3 4 5 6 7 8 9 10 11 12 > >>